1. Muscle electrolyte (Na, K, Cl, P) concentra tions and fluid compartments of six children with Bartter's syndrome were compared with those of 17 control children. From four of the patients biopsies were taken twice, before and after treat ment with potassium chloride and spironolactone. Muscle electrolytes were determined by neutron activation in tissue sampled by needle biopsy. Results were expressed in relation to fat-free dry solids. Trapped extracellular fluid was calculated from the chloride space, a normal resting mem brane potential being assumed.
Introduction
In their description of the syndrome of hypokalaemic alkalosis with hyperaldosteronism and hyperplasia of the juxtaglomerular complex, Bartter, Pronove, Gill & MacCardle (1962) men tioned muscle chemical anomalies in one of the two recorded cases. Before the description of this entity, muscle electrolytes had been studied by Slater, Azzopardi, Slater & Chute (1958) and Cheek, Robinson & Collins (1961) in children with the same clinical symptoms. These investigators found a decrease in muscle potassium. There was a discrepancy in the data for muscle sodium, which was increased in Bartter's and Slater's studies and decreased in that of Cheek. These studies were incomplete and did not give adequate information on muscle electrolyte changes in this disease.
According to our knowledge, except for the work of Haljamäe, Enger & Sigström (1975) there have been no further studies of electrolyte muscle content in the syndrome of idiopathic hypokalaemia although erythrocytes have been used as a cell model (Gall, Vaitukaitis, Haddow & Klein, 1971 ; Gardner, Simopoulos, Lapey & 223 Shibolet, 1972) . Since body potassium is largely found in muscle, and having a simple technique to sample this tissue, we chose to study the muscle of six children hospitalized for Bartter's syndrome. Four electrolytes (Cl, Na, K, P), total muscle water and the partition between extra-and intra-cellular fluid compartments were determined. The influence of treatment on these variables was also evaluated. Altered sodium membrane transfers described for erythrocytes were an additional reason to study electrolyte anomalies in muscle cells.
This work was presented in part at the X meeting (1 July 1976) of the European Society for Paediatric Nephrology, Barcelona, Spain.
Methods

Subjects
Biopsies were taken from six children with Bartter's syndrome aged 2-12 years. Five of the six children had started their disease in infancy, their first symptoms being growth retardation and polydipsia. The sixth child was admitted for acute hepatitis. Routine laboratory investigations revealed a persistent hypokalaemia. Five were boys, one was a girl; one child (no. 3) was black. Three had a family history of hypokalaemia. Physical examination revealed dwarfed children with severe growth retardation in five cases. Three had peculiar triangular facies with large foreheads.
Bartter's syndrome was diagnosed from a low plasma potassium concentration (1-8-2-5 mmol/1), associated with renal potassium wasting, metabolic alkalosis (plasma bicarbonate > 29 mmol/1), hyperaldosteronism (urinary tetrahydroaldosterone > 100 ,ug/24 h), abnormally high plasma renin activity (>23 pmol of angiotensin I h _1 ml -1 ) and normal blood pressure for age. None had renal insufficiency at the time of the study (plasma creatinine 0-03-0-06 mmol/1). Five had a urinary concentrating defect (maximal osmolality 574 mosmol/kg). No other signs of tubular dysfunction were found except for hypercalciuria (>2 mmol day -1 kg -1 ) in three cases. Renal biopsy demonstrated hyperplasia of the juxtaglomerular complex and immature glomeruli in five cases. In one child (no. 6) renal biopsy showed only four glomeruli, which were normal.
All the patients were treated with potassium supplements and spironolactone. The first muscle study was performed before treatment in all children except no. 2, who received potassium supplements; in four children a second muscle biopsy was made after combined spironolactone and potassium chloride treatment. One child (no. 3) had a third biopsy taken when hyperkalaemic (plasma potassium 7-2 mmol/1), due to functional renal insufficiency after acute diarrhoea while the potassium supplement was continued.
Muscle biopsies were not taken during the periods of metabolic studies such as sodium loading or restriction, angiotensin II, albumin or sodium chloride infusions. The purpose of the study and the details of the procedure were explained to all parents. Muscle biopsies were undertaken after obtaining their written consent. This study received ethical approval by the Research Committee on the grounds that it could lead to changes in therapy for the patient's benefit.
Muscle sampling
Muscle tissue was obtained in the middle of the quadriceps femoris muscle by needle biopsy (Baylor biopsy needle modified for sampling in children; Collin-Gentile, Paris, France) according to a technique utilized in both adults (Bergström, 1962) and children (Nichols, Hazlewood & Barnes, 1968) . When the muscle biopsy was taken out of the needle, a stopwatch was started. The biopsy, which weighed less than 10 mg, was cut into two pieces for duplicate analysis, after removing blood, connective tissue and fat. Each piece was placed on a hook of known weight made of an extremely pure aluminium (99-995% Al). As the desiccation of the tissue is linear during the first 10 min, the muscle wet weight was determined by extrapolation to zero time of serial timed weights (Cahn Electrobalance, model Gil; Cahn Instrument Co., Calif, U.S.A.). "Total muscle water was obtained from weights obtained after drying for 2 h at 95°C. The fat was extracted with light petroleum (boiling point 40-60 °C), the weight afterwards giving the weight of fat-free dry solids.
Analytical methods
Electrolytes were determined by neutronactivation analysis (Bowen & Gibbons, 1963; Batra, Bewley, Edwards & Jones, 1976 K emitted both y and ß radiations, it was necessary to wait for extinction of their activity before assaying phosphorus [ 10 i 0 . 5 for Na= 15 daysl.
Fluid compartments
Total muscle water (W v ml/kg of muscle) was determined by the difference between the wet weight and the dry weight of each sample. The partition into extra-and intra-cellular water, and the cell concentration of electrolytes, were estimated by the chloride method. Chloride was considered as passively diffusible across the cell membrane. The extracellular concentration (Cl e ) was calculated from the plasma concentration after taking into account the Gibbs-Donnan factor of 0-960 and the volume of plasma water. This volume was calculated with the Eisenman, MacKenzit & Peters (1936) equation according to plasma protein concentration for each subject. Intracellular chloride (Cl,) was obtained according to the Nernst equation, by assuming a normal resting muscle membrane potential (E m ) as determined by Riecker, Bolte & Röhl (1963) . For E m -87-2 mV at 20°C, the Cl/Cl, ratio was 26. Knowing chloride distribution, extracellular water (W e , ml/kg of muscle) was calculated according to the equation of Graham, Lamb & Linton (1967) :
Cl t being muscle chloride (mmol/kg of muscle) determined by analysis, W t is total muscle water (ml/kg of muscle) obtained by weighing, [Cl e ] and [Cl,l are extra-and intra-cellular concentrations of chloride (mmol/1 of water) as calculated above. The intracellular water (W { ) was calculated from the difference between total muscle water and extra cellular water.
The intracellular electrolyte concentration (A e ) was determined by subtracting the extracellular part from the total amount (A m ), the extracellular electrolyte concentration being assumed to be the same as the plasma concentration (A p ).
Muscle fluid and electrolyte content was expressed in relation to fat-free dry solids.
Statistical analyses of results were made by unpaired ί-tests for the comparison between the values for patients and the normal values, the paired f-test being used for the analysis of changes introduced by the treatment in the same patient. Values are given as mean ± 1 SEM.
Plasma and urine analyses were made according to routine methods in the clinical laboratory. Venous blood was analysed for electrolytes and total protein. Capillary blood from the finger tips was collected for the determination of pH and bicarbonate. Maximal urinary osmolality was measured after 12 h of water restriction. Plasma renin activity was determined by radioimmunoassay according to the technique of Valloton (1971) (normal values 1-00 ± 0-38 pmol of angiotensin I h _l ml -1 ). Venous blood was taken in the morning after the child had been recumbent over night. Urinary tetrahydroaldosterone excretion was measured by the method of Legrand, Legrand, Zogbi & Guillemant (1967) (normal values 40-60 //g/24 h). Growth was evaluated in standard deviations of the normal mean for age according to standardized charts of Sempe & Masse (1965) for normal French children.
Results
Muscle values are recorded in Table 1 . In the four cases with repeated biopsy, the results are success ively reported for each treatment. These data were compared with those of 17 normal children of similar age from whose quadriceps femoris a biopsy was taken during orthopaedic surgery, with parental consent (Delaporte, Broyer & Maziere, 1974) . Relationship of (a) plasma potassium concentration (K p ) to total muscle potassium (K m ) in patients with Bartter's syndrome (r = 0-87; P < 0-01), and (6) relationship of K p to intracellular potassium concentration (K,) in the same patients (r = 0-83: P > 0-01). The broken lines delineate +2 SD of the normal mean value. For each patient, the arrows connect the basal value and the value under treatment and in one patient the third point shows the state in hyperkalaemia.
Muscle electrolyte content
In all the untreated patients the muscle potassium content (K m ) was significantly de creased: 33-0 ± 2-1 mmol/100 g for the patients and 43-8 ± 0·7 mmol/100 g of fat-free dry solids for the control children (P<001). When sup plemented with potassium chloride and/or treated with aldosterone antagonists, the four children recovered a normal muscle potassium value (43-8 ±0-9 mmol/100 g). An increase in muscle sodium was found in the patients with muscle potassium wasting (18-7 + 2·9 mmol/100 g, against 11-3 ± 0·6 mmol/100 g in control children. A negative relationship was found between muscle potassium and muscle sodium (Fig. 1 ). There was a significant correlation between plasma potassium and muscle potassium (Fig. 2a) .
Muscle chloride was normal or elevated despite a low plasma chloride (ranging between 71 and 97 mmol/l). Muscle phosphorus was within the normal range in all untreated cases. However, three of the treated patients showed a large increase, which exceeded the upper limit of normal (32-1 ± 1-8 mmol/100 g of fat-free dry solids against 28· 1 ± 1-1 mmol/100 g in control children). At the same time no change was noted in plasma phosphorus, which remained normal or low. 
Calculated values of fluid compartments and intracellular concentration of sodium and potassium (Fig. 3)
The measured total water was normal or high in untreated children. An increase of muscle fluid appeared in three of the four treated patients. The extracellular water calculated from chloride space was normal in basal conditions in three patients and high in three others; with treatment this space returned to within normal range in all patients. The calculated intracellular water was normal in all untreated children except one, whose value was slightly low. When treatment was given, the mean intracellular fluid compartment rose to 307-5 g/100 g from 259 g/100 g before treatment (P < 0-02). This increase was similar in all treated patients (+15% for three, +11% for one) and went beyond the upper limit of normal in three patients (Fig. 3) .
The calculated intracellular potassium concen tration (K|) correlated directly with plasma potassium (Fig. 2b) , but of three patients who recovered a normal serum potassium in two the intracellular potassium remained low. A significant negative relationship was found between intracellular sodium concentration (Na,) and intracellular water (W,), except in patient no. 3 (Fig. 4a) . With effective treatment intracellular sodium concentration fell markedly in three patients who gained a normal serum potassium. However, as intracellular volume increased, the quantity of sodium in the cell did not change. In contrast no relationship was found between intra cellular potassium concentration and intracellular water (Fig. 4b) . Without treatment the children had a low potassium concentration in the cells (126-5 ± 5 mmol/1 of intracellular water). When treated, their cellular potassium concentration remained significantly low (P < 0-01) and the increase from 126-5 to 142-0 mmol/1 of intra cellular water was not significant. The sister of no. 3 had been binephrectomized and haemodialysed twice a week for more than 3 years, when the biopsy was taken. Before dialysis her intramuscular potassium was low (134 mmol/1 of intracellular water) and yet her plasma potassium was 5 mmol/1. Intracellular water exceeded the predicted values for the sum (Na, + K,). On the other hand, the sum of these two cations was lower in children with Bartter's syndrome than in control children (154-5 ± 6 -9 against 171-6 + 2-9 mmol/1 of intracellular water in control children; P < 0-02). The slight in crease observed with treatment was not significant.
Discussion
This study confirms that muscle potassium is decreased in children with chronic hypokalaemrc alkalosis (Bartter et al., 1962; Slater et al., 1958; Cheek et ah, 1961) . However, in our patients, the diminution of muscle potassium was greater than in previous studies. The mean decrease was 25% and in one patient (no. 1: plasma potassium 1-8 mmol/1) the decrease was as much as 33-6% of the normal mean value. Cheek et al. (1961) found a decrease of muscle potassium of only 14% in a patient with the same degree of hypokalaemia.
In published reports and in their own cases Royer, Delaitre, Mathieu, Gabilan, Raynaud, Pasqualini, Debris, Gerbeaux & Habib (1964) noted a discrepancy between plasma potassium and exchangeable body potassium or muscle potassium, these last two not being as low as might be predicted from the plasma potassium con centration. We found a significant correlation between plasma potassium and muscle potassium in 11 biopsies. These results show that the total muscle potassium content (as distinct from intra cellular potassium concentration) is reflected by the plasma potassium concentration.
None of our children with a marked muscle potassium depletion had any clinical manifestation of potassium wasting. It thus appears that even a severe loss of cell potassium is insufficient by itself to induce paralysis.
Reduced muscle potassium is not confined to Bartter's syndrome, being found with chronic potassium depletion of any cause, such as renal tubular acidosis (Torres-Pinedo, Kooh & Metcoff, 1966) , or chronic diarrhoea with great intestinal potassium losses (Valentin, Nielsen & Olesen, 1975; Bergström, Alvestrand, Fürst, Hultman, Sahlin, Vinnars ÄWidström, 1976) . In our unpub lished study of patients with tubular diseases (Albright-Fanconi syndrome and cystinosis) the decrease in muscle potassium was not as great as in Bartter's syndrome. In all these cases muscle potassium concentration returned to normal with appropriate treatment.
The present study has shown a clear relation ship between the total potassium and total sodium in muscle. Sodium is the most important extra cellular cation and it is conceivable that it replaces a portion of the potassium lost by the cell. This finding confirms that in potassium depletion sodium is exchanged for potassium in skeletal muscle. As observed by Bartter, we have found that the amount of sodium gained in the whole muscle was quantitatively equivalent to the amount of the potassium lost.
However, the sum of the cellular concentration of these two cations was lower in our patients than in the control subjects. Cheek et al. (1961) and Torres-Pinedo et al. (1966) found a diminution of muscle sodium. In Cheek's report this reduced total muscle sodium could be due to a markedly decreased extracellular fluid compartment The patients of Torres-Pinedo had metabolic acidosis and it is likely that the intracellular pH was also decreased. The cation gap due to the loss of both sodium and potassium could be supposed to be filled by hydrogen ions, or more likely by an accumulation of basic free amino acids in muscle (Bergström et al, 1976) .
Erythrocyte sodium content has been estimated in Bartter's syndrome by several investigators (Gall et al, 1971; Gardner et al, 1972) . All of them observed a large increase of this ion, although these papers had different explanations for the mechan ism of sodium retention. Unfortunately erythrocyte potassium was not determined at the same time.
Concomitantly with low muscle total potassium, muscle phosphorus remained normal or slightly elevated. In the four patients in which repeated biopsies were made, muscle phosphorus increased markedly in two after effective treatment of hypo-kalaemia. In these phosphorus concentration ex ceeded even the highest values previously found in children with terminal renal failure (Broyer, Delaporte & Maziere, 1974) . Before discussing these results we should emphasize that the method of phosphorus determination detected the phosphorus atom including the inorganic phosphorus and the phosphorus bound to organic compounds, especially adenosine triphosphate (ATP). In the muscle of our patients the cellular cationic concentration was lower than in control children. On the other hand, plasma phosphate was normal or low. For these two reasons it is unlikely that the increased muscle phosphorus was present as inorganic anion. The experimental studies of Gall et al. (1971) and Gardner et al. (1972) have demonstrated a rise of the Na + + K + -dependent adenosine triphosphatase activity in the erythrocytes of patients with Bartter's syndrome. Thus it is conceivable that phosphorus was retained in muscle as organic compounds, mainly as ATP.
It is necessary to discuss the method of calculation for the estimation of extracellular space in order to interpret the results concerning fluid compartment and cellular electrolyte concen tration. This calculation is based on the assumption that chloride is freely diffusible across the cell membrane. The calculation of chloride space supposes that the resting membrane potential is known.
In many metabolic diseases membrane potential is changed. No E m determinations were performed in patients with Banter's syndrome. Nevertheless, some experimental studies have demonstrated a decrease of E m in severe potassium depletion. Kendig & Bunker (1970) induced chronic potassium depletion in rats with potassiumdepleting diets and observed a decline of resting membrane potential (from -73-7 to -89-2 mV) in muscle after 3 months of this diet. Bilbrey, Herbin, Carter & Knöchel (1973) in other experimental studies of potassium depletion observed an elevated E m in modest potassium depletion and a decreased E m in severe potassium deficiency; a low E m would therefore be expected in Bartter's syndrome. In our children ethical considerations did not allow measurement of E m in situ. Thus in untreated patients extracellular space would have been over estimated and intracellular space underestimated if the membrane potential was in fact lower than normal. Consequently intracellular potassium was lower when calculated with E m = -70 mV instead of-87 mV; for example, in no. 3 K, calculated with E m -87 mV was 130 mmol/1 and with E m -70 mV it was 95 mmol/1. Extracellular compartment was normal or high in our untreated children. The trapped extracellular fluid (bromide space) was estimated in four of these children under identical conditions. Normal values were found in each case. With treatment, inter stitial fluid decreased but remained within the normal range. These findings are an additional argument to those of James, Holland & Preston (1975) and other authors to refute the explanation that high plasma renin activity and hyperaldosteronism could be an effect of hypovolaemia.
All treated children were given potassium supplements, and in addition three of them received aldosterone antagonists. For these latter patients, the decrease of extracellular space may be regarded as a direct effect of a reduction of hyperaldosteronism. Most interesting to consider is the child treated only with potassium supplements (no. 3). His decrease in extracellular space was of the same magnitude as that of a child (no. 4) who received spironolactone. This suggests that chronic hypokalaemia by itself may induce hyperreninaemia with a secondary hyperaldosteronism.
The mechanism of the increase of intracellular volume with treatment is difficult to explain. It is noteworthy that in the same conditions the intra cellular concentration of potassium did not become normal. Intracellular volume exceeded the normal range for treated children, and on recovery all of them had exactly the same quantity of pofassium (measured by the product K, x W) as the control children in their muscle cells. Thus it can be concluded that the cells of children with Bartter's syndrome are unable to achieve a normal concen tration of potassium. This conclusion holds even if membrane potential is decreased, intracellular space being higher.
Experiments on erythrocytes have showed diminished sodium efflux in the Gardner et al. (1972) study and an increased influx with dec reased efflux in the Gall et al. (1971) study. Both found increased total sodium in erythrocytes as in muscle in our study.
It is an open question whether Bartter's syn drome is a renal or a general disease. The tubular defect of potassium reabsorption is clearly defined by many studies. There is no agreement as to whether the primary defect is an excess of sodium excretion or a defect of potassium reabsorption. The cationic modifications observed in erythrocytes and muscle cells both in vitro and in vivo permit the conclusion that Bartter's syndrome is a generalized disorder of cation transport across cell membranes as suggested by Gardner et al. (1972) . First, the large potassium depletion in untreated patients with Bartter's syndrome was never corrected by any treatment. Our only case with normal cell potassium concentration was encountered in an unstable state of excessive hyperkalaemia. On the other hand, in two new cases recently treated with indomethacin, which nor malized plasma potassium, plasma renin activity and the urinary prostaglandins, muscle potassium remained low after 3 months of treatment. This failure to establish normal trans-membrane potassium gradients can be considered as the major difference between Bartter's syndrome and other states of low K,. Secondly, our anephric patient had a low intracellular potassium concentration despite a high plasma potassium. Our findings support the view that Bartter's syndrome results from a primary defect of membrane function of all cells rather than to secondary metabolic modifications arising from a primary renal tubular dysfunction.
